AAP Implantate AG Announces Upcoming Financial Reports

On May 16, 2025, AAP Implantate AG, a prominent medical technology company based in Germany, announced the forthcoming publication of its financial reports. The company specializes in the development, manufacturing, and marketing of biomaterials and implants for ortho/trauma/spine sectors, including bone cements, bone graft substitutes, antibiotic carriers, and implants for fracture healing and joint replacement.

The announcement, transmitted by EQS News, a service of the EQS Group, indicates that AAP Implantate AG will release two key financial reports. The first report, an annual financial report, is scheduled for publication on May 19, 2025. The second report, an annual financial report of the group, will also be available on the same date. Both reports will be published in German and can be accessed at AAP’s investor publications page .

This announcement follows a previous notice indicating that the financial reports would be published on June 20, 2025. The discrepancy in dates highlights the dynamic nature of financial reporting timelines.

AAP Implantate AG is listed on the Xetra exchange and operates within the Health Care Equipment & Supplies sector. As of May 14, 2025, the company’s close price was €1.23, with a 52-week high of €2.98 and a low of €1.06. The market capitalization stands at €19,750,000, and the price-to-earnings ratio is currently -3.44, reflecting the company’s financial performance and market valuation.

Investors and stakeholders are encouraged to review the upcoming financial reports for detailed insights into AAP Implantate AG’s financial health and strategic direction. For further information, interested parties can visit the company’s website at www.aap.de or follow the reports on Xetra.